Skip to main content
. 2020 Jul 29;15(3):351–361. doi: 10.18502/jovr.v15i3.7454

Table 2.

Clinical characteristics of the study subjects


Groups
Parameters Level Total ( n = 612) RP ( n = 264) Stargardt ( n = 76) Cone- Rod Dystrophy (n = 109) Usher Syndrome ( n = 54) Control ( n = 109) P -value
BCVA (LogMAR) Mean ± SD 1.04 ± 0.91 1.19 ± 0.98 1.02 ± 0.47 1.43 ± 0.87 0.84 ± 0.69 0 ± 0 < 0.001
Median (range) 0.8 (0 to 2.79) 0.8 (0 to 2.79) 0.9 (0.1 to 2.31) 1.31 (0 to 2.7) 0.74 (0.1 to 2.7) 0 (0 to 0)
SE (D) Mean ± SD –1.0 ± 1.78 –0.88 ± 1.79 –1.54 ± 1.33 –0.88 ± 2.07 –1.67 ± 1.94 –0.33 ± 0.94 < 0.001
Median (range) –0.75 (–6.63 to 2.75) –0.5 (–5.75 to 2.75) –1.25 (–5.25 to 0.75) –0.31 (–6.63 to 2.63) –1.5 (–5.75 to 1.5) –0.38 (–2 to 2)
CMT (µm) Mean ± SD 215.99 ± 72.1 230.66 ± 68.81 165.54 ± 65.04 186.03 ± 48.59 244.88 ± 99.87 258.72 ± 15.71 < 0.001
Median (range) 213 (80 to 690) 222 (95 to 674) 141 (80 to 378) 186.5 (88 to 317) 229.5 (90 to 690) 259.5 (220 to 285)
Color Vision Normal 164 (28.1%) 40 (16.1%) 6 (8.3%) 2 (1.9%) 7 (14.6%) 109 (100.0%) < 0.001
CVD 213 (36.5%) 71 (28.6%) 53 (73.6%) 62 (57.9%) 27 (56.3%) 0 (0.0%)
N/A 207 (35.4%) 137 (55.2%) 13 (18.1%) 43 (40.2%) 14 (29.2%) 0 (0.0%)
Cataract Type (%) No 376 (62.0%) 101 (38.5%) 69 (95.8%) 80 (73.4%) 17 (31.5%) 109 (100.0%)
CC 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) < 0.001
NS 44 (7.3%) 29 (11.1%) 0 (0.0%) 11 (10.1%) 4 (7.4%) 0 (0.0%)
PSC 169 (27.9%) 120 (45.8%) 3 (4.2%) 16 (14.7%) 30 (55.6%) 0 (0.0%)
PCIOL 14 (2.3%) 12 (4.6%) 0 (0.0%) 2 (1.8%) 0 (0.0%) 0 (0.0%)
Posterior Polar 3 (0.5%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (5.6%) 0 (0.0%)
Optic Atrophy (%) No 46 (9.1%) 10 (3.8%) 22 (28.9%) 14 (12.8%) 0 (0.0%) 0 (0.0%) < 0.001
Yes 457 (90.9%) 254 (96.2%) 54 (71.1%) 95 (87.2%) 54 (100.0%) 0 (0.0%)
Macular Involvement (%) No 122 (19.9%) 11 (4.2%) 0 (0.0%) 2 (1.8%) 0 (0.0%) 109 (100.0%) < 0.001
Yes 490 (80.1%) 253 (95.8%) 76 (100.0%) 107 (98.2%) 54 (100.0%) 0 (0.0%)
RP, retinitis pigmentosa; BCVA, best corrected visual acuity; LogMAR, logarithm minimum angle of resolution; SE, spherical equivalent; D, diopter; CMT, central macular thickness; µm, micrometer; CVD, color vision defect; N/A, not applicable; CC, cortical cataract; NS, nuclear sclerotic; PSC, posterior subcapsular; SD, standard deviation; n, number *These parameters are presented based on monocular findings